ClearPoint Neuro, Inc. (CLPT) vs Opus Genetics, Inc. (IRD)
A side-by-side comparison of ClearPoint Neuro, Inc. and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLPT
ClearPoint Neuro, Inc.
$11.06HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
IRD
Opus Genetics, Inc.
$4.42HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
Total return — CLPT vs IRD
growth of $100 · dividends reinvested · last 2yCLPT +1.1% (+0.5%/yr)IRD +239.5% (+84.3%/yr)IRD compounded faster over this window
CLPT IRD
CLPT vs IRD: by the numbers
- •IRD is the larger company ($365M vs $332M market cap).
- •Both run net losses; CLPT's is the smaller (-81.76% vs -1091.82% net margin).
- •IRD grew revenue faster over the past five years (150.49% vs 23.57% CAGR).
Metrics side by side
Valuation
| Metric | CLPT | IRD |
|---|---|---|
| P/S ratio | 7.85 | 36.99 |
| P/B ratio | 30.78 | N/A |
Profitability
| Metric | CLPT | IRD |
|---|---|---|
| Gross margin | 62.61% | 99.87% |
| Operating margin | -65.36% | -271.90% |
| Net margin | -81.76% | -1091.82% |
| ROE | -320.77% | N/A |
| ROIC | -40.51% | -59.29% |
Growth (annualized)
| Metric | CLPT | IRD |
|---|---|---|
| Revenue CAGR (5Y) | 23.57% | 150.49% |
| Total return CAGR (5Y) | -7.65% | N/A |
Frequently asked
- Which has grown faster, CLPT or IRD?
- Over the past five years, IRD grew revenue faster — CLPT at a 23.57% CAGR versus IRD at 150.49%.
Go deeper
Dig into the metrics
ClearPoint Neuro ROEOpus Genetics ROEClearPoint Neuro operating marginOpus Genetics operating marginClearPoint Neuro revenue growthOpus Genetics revenue growthClearPoint Neuro free cash flowOpus Genetics free cash flow
ClearPoint Neuro & Opus Genetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.